• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

No wonder the White House wants Warsh to cut: A 1% Fed rate hike costs the Treasury an extra $95 billion a year in national debt interest

2

United Airlines CEO—who made $32 million last year—calls for a national wealth tax and a nearly 100% inheritance tax: 'I would pay them'

3

UnitedHealthcare and Humana are ending Medicare Advantage plans for nearly 1 million people

1

No wonder the White House wants Warsh to cut: A 1% Fed rate hike costs the Treasury an extra $95 billion a year in national debt interest

2

United Airlines CEO—who made $32 million last year—calls for a national wealth tax and a nearly 100% inheritance tax: 'I would pay them'

3

UnitedHealthcare and Humana are ending Medicare Advantage plans for nearly 1 million people
C-SuiteMark Cuban

Billionaire Mark Cuban’s 5-step plan to make healthcare affordable targets drug middlemen’s ‘contractual terrorism’

By
Emma Witman
Emma Witman
Down Arrow Button Icon
By
Emma Witman
Emma Witman
Down Arrow Button Icon
October 21, 2026, 3:15 AM ET
Mark Cuban
Mark CubanShafkat Anowar/The Dallas Morning News via Getty Images
Google source logo
Add Fortune on Google for similar content.

Mark Cuban says many of the customers flooding his low-cost pharmacy have something in common: They already have insurance. And they’re still better off paying cash.

Recommended Video

“They come to us because our cash price is often lower than what their insurance plan asks them to pay,” Cuban told Texas House lawmakers on Sept. 1. “That tells you something is wrong.”

The billionaire Cost Plus Drugs cofounder and former Shark Tank star used the hearing to prescribe five steps to fix America’s healthcare affordability crisis, which has left a record 51% of U.S. adults unable to reliably afford quality care, according to West Health-Gallup. Many of his remedies share a common active ingredient: transparency.

Mark Cuban’s 5-step plan to fix healthcare costs

  • Let insured patients choose the cheapest option—without penalty. If a prescription costs $500 through insurance but $100 through Cost Plus Drugs, patients should be able to take the cheaper route and have that spending count toward their deductibles and out-of-pocket maximums. “Patients should be rewarded for saving themselves and their health plan money. They shouldn’t be punished for it,” Cuban said. “That’s how you create something healthcare desperately needs: price competition.”
  • Standardize contracts for drug middlemen. Cuban wants standardized contracts for pharmacy benefit managers (PBMs) and third-party administrators. Three PBMs—CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx—handle roughly 80% of U.S. drug claims. Their contracts can run hundreds of pages, making harmful terms easy to bury. “I call it contractual terrorism,” Cuban said. He has drafted a model PBM contract that states, cities, counties, and school districts could use as a template. “Just stop making every government entity negotiate these contracts from scratch,” he said. “It’s a losing game for everybody.”
  • Make pricing public wherever taxpayers foot the bill. Any taxpayer-funded program, including Medicare and Medicaid, should be required to disclose pricing data such as rebates, fees, guarantees, and affiliate compensation. Without that “price discovery,” Cuban argued, a market can’t function efficiently when one party holds all the information.
  • Eliminate gag clauses. These provisions keep employers and plan sponsors from openly discussing their contract terms, which Cuban said blocks them from comparing fees and negotiating better deals.
  • Give enforcement real teeth. Regulators could go easy on a first significant violation, Cuban said, but should hit repeat offenders with much steeper penalties. Under the current system, he said, “some of these companies can make billions, get caught, pay a fine,” and “write it off more easily than I wrote off my NBA fines.” He added: “That’s not deterrence. That’s a cost of doing business for them.”

Cuban’s unlikely allies in Washington

Cuban’s crusade on drug prices has made for strange bedfellows. In May, TrumpRx, the White House-backed discount drug site, added more than 600 generic medications through Cost Plus Drugs, alongside Amazon Pharmacy and GoodRx. The deal put Cuban on the same side as President Donald Trump, who called him “a loser” during the 2024 campaign.

Cuban also threw his support in March behind the Break Up Big Medicine Act from another odd couple: Sens. Josh Hawley (R-Mo.) and Elizabeth Warren (D-Mass.). The bill would bar a single company from owning both an insurer or PBM and medical providers. It has been referred to the Senate Judiciary Committee and hasn’t advanced, but Cuban has kept pressing the case, recently arguing that rising healthcare costs, not AI, are the real threat to American jobs.

Fortune Daily breaks the traditional barrier between audience and newsroom. The show transforms Fortune’s trusted reporting into actionable, conversational, and entertaining insights for an emerging class of business leaders. Watch here.
About the Author
By Emma Witman
See full bioRight Arrow Button Icon
Google source logo
Add Fortune on Google for similar content.

Latest in C-Suite


Most Popular

Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    Recommended For You

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.